Answers are grounded in this paper and cite their sources.
Introduction: Inadequate zinc and magnesium intakes affect about 16% and 31% of the world’s population, respectively, and mineral salts used for correction have limited, form-dependent bioavailability. This study evaluated zinc- and magnesium-biofortified Pleurotus eryngii mycelial biomass as a candidate functional food ingredient. Methods: Strain MT-40.32 was pre-cultivated in submerged medium with magnesium and zinc sulfates at a calculated (X1) or double (X2) dose and grown by solid-state fermentation (SSF) on buckwheat hull-wheat bran (70:30) for 21 days. A mycelium-rich fraction of the freeze-dried colonized substrate was analysed for 40 elements by ICP-MS and assessed against TR CU 021/2011 and GOST R 52349-2005. Results: Relative to control biomass, magnesium increased 1.49-fold at X1 and 9.95-fold at X2 (3688 ± 369 µg/g) and zinc 2.39- and 3.80-fold, respectively; a mass balance indicated proportional zinc but disproportionate magnesium transfer. In X2 biomass all regulated toxic elements were below their limits on the dry-weight basis (mercury 36.2 ± 5.4%), whereas mercury exceeded the limit in control and X1 biomass. A 30 g portion of X2 biomass would supply 27.7% of the magnesium and 19.7% of the zinc reference intake. Novelty of the Study: This is the first full report of combined zinc and magnesium biofortification of P. eryngii by SSF on buckwheat hull with 40-element safety screening. Conclusions: In this single-lot study only X2 biomass met both the nutrient-contribution criterion and the regulatory limits. Replicate fermentations, mercury-specific analysis, bioaccessibility testing and clinical validation must precede functional food claims.
No takes yet. Share an insight, caveat, or question.
Sugueva et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: